Neuca S.A. (NEU)
GPW
Real-time Data
07:00 AM
Day's Range
755.0052 wk Range
645.00Overview - NEU - Neuca S.A.
Key Statistics
Valuation
Enterprise Value
4.25B
P/E (Trailing)
‪19.86‬
P/E (Forward)
‪13.89‬
PEG Ratio
‪0.49‬
Price / Sales (TTM)
‪0.24‬
Price / Book
‪2.97‬
EV / EBITDA
‪12.28‬
Profitability
Gross Margin
‪12.03%‬
Profit Margin
‪1.26%‬
Operating Margin
‪2.71%‬
Return on Assets
‪2.83%‬
Return on Equity
‪12.38%‬
Ownership
Shares Outstanding
4.50M
Float
1.62M
Held by Insiders
‪60.58%‬
Held by Institutions
‪9.96%‬
Price stats
Beta
‪0.46‬
50-Day Avg
‪738.06‬
200-Day Avg
‪756.24‬
Dividends
Payout Ratio
‪41.83%‬
Frequency
Annual
Analyst Consensus
5 analysts
Average price target
‪PLN 922.64‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - NEU - Neuca S.A.
Peers - NEU - Neuca S.A.
Peer Comparison
Compared with companies in Medical Distribution listed on GPW.
- NEUGPWNeuca S.A.3.41BMarket Cap+12.70%52-week change20.20P/E (Trailing)‪1.26%‬Profit Margin
- SPHGPWSopharma AD4.43BMarket Cap-51.79%52-week change32.31P/E (Trailing)‪5.76%‬Profit Margin
- NVGGPWNovavis Group S.A.24.16MMarket Cap-87.25%52-week change172.00P/E (Trailing)‪204.81%‬Profit Margin
Profile Summary - NEU - Neuca S.A.
About
Neuca S.A. is a leading healthcare company, primarily focused on the wholesale distribution of pharmaceuticals across Poland. The company's primary function is to ensure the efficient supply of pharmaceutical products to pharmacies, hospitals, and healthcare institutions, thereby playing a crucial role in the…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
